lycorine has been researched along with su 11248 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
| Li, X; Lv, F; Wang, Y | 1 |
1 review(s) available for lycorine and su 11248
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
1 other study(ies) available for lycorine and su 11248
| Article | Year |
|---|---|
Lycorine inhibits angiogenesis by docking to PDGFRα.
Topics: Amaryllidaceae Alkaloids; Angiogenesis Inhibitors; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Neoplasms; Neovascularization, Pathologic; Phenanthridines; Receptor, Platelet-Derived Growth Factor alpha; Sunitinib | 2022 |